AI주식인사이트AI Stock Insight
B

블루엠텍

439580KOSDAQ

57.8 / 100

Reference Date: 2026-09-08

Financial Score17.5 / 40
News Sentiment21.3 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 17.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BlueEmtek operates pharmaceutical distribution platforms such as BluePharmKorea and KoolPharm, selling specialized medications to hospitals and pharmacies. The company also provides the online order management system 'BOS' and cold chain logistics solutions to enhance pharmaceutical distribution efficiency, and operates a medical staffing platform called BlueDoc.

Number of Employees

98people

Average Salary

48.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
1.52Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
-9.81Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
20.30Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲28.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼270.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -10.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 2,020Won52-week high 6,42052-week low 1,466
1-month return6.0Point

1m +17.85% (strong rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14